Andorra vs Norway: Measles-containing-vaccine second-dose (MCV2) immunization coverage
Andorra
96.0%
in 2025
Norway
95.0%
in 2025
Andorra rank
26th
Norway rank
29th
Measles-containing-vaccine second-dose (MCV2) immunization coverage over time
- Andorra
- Norway
How they compare
Andorra currently reports 96.0% against 95.0% in Norway, a difference of 1.0%.
The two have swapped places 3 times across 26 shared years of data; in 2000 it was Norway ahead.
Andorra ranks 26th and Norway ranks 29th of 194 countries.
Across the 3 decades both report, Andorra averaged higher in 1 and Norway in 2.
Head to head by decade
| Decade | Andorra | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 24.8% | 91.5% | 66.7% | Norway |
| 2010s | 90.2% | 92.6% | 2.4% | Norway |
| 2020s | 95.8% | 94.5% | 1.3% | Andorra |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher measles-containing-vaccine second-dose (mcv2) immunization coverage, Andorra or Norway?
- Andorra, at 96.0% against 95.0% in Norway as of 2025.
- What is the difference in measles-containing-vaccine second-dose (mcv2) immunization coverage between Andorra and Norway?
- 1.0%, with Andorra ahead.
- How many years of comparable data are there for Andorra and Norway?
- 26 years are reported by both, from 2000 to 2025.
- How do Andorra and Norway rank globally for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Andorra ranks 26th and Norway ranks 29th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.